Spine radiosurgery for spinal cord compression: the radiation oncologist's perspective

Area of Science:

• Oncology
• Neurosurgery
• Radiotherapy

Background:

• Metastatic spinal cord compression (MSCC) affects 5-14% of cancer patients, presenting a significant clinical challenge.
• MSCC is a medical emergency associated with severe morbidity, including pain, paralysis, and incontinence.
• Current therapies, including corticosteroids and radiotherapy (RT), often yield unsatisfactory results, highlighting the need for optimized treatment strategies.

Purpose of the Study:

• To review the current understanding and management of metastatic spinal cord compression (MSCC).
• To emphasize the importance of timely diagnosis and intervention in MSCC cases.
• To discuss the need for optimal therapeutic approaches to improve patient outcomes and quality of life.

Main Methods:

• Review of existing literature on metastatic spinal cord compression (MSCC).
• Analysis of epidemiological data and treatment outcomes for MSCC.
• Discussion of current therapeutic modalities including corticosteroids, radiotherapy (RT), and surgery.

Main Results:

• MSCC impacts over 20,000 individuals annually in the US, presenting a substantial public health concern.
• Delayed or inadequate treatment of MSCC leads to significant patient morbidity and mortality.
• While many patients succumb to cancer within a year, a notable proportion survive longer, underscoring the need for sustained quality of life.

Conclusions:

• Metastatic spinal cord compression (MSCC) necessitates urgent, multidisciplinary intervention.
• Effective management strategies are vital for mitigating MSCC-related complications and enhancing patient survival.
• Further research into optimizing MSCC therapies is essential to improve long-term quality of life for cancer survivors.